Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4058 results

Sort By:

Effectiveness of a Customized Digital Platform to Increase Coordination of Care and Uptake of Evidence-based Practices

Study ID: NCT06867081
Start Date: 2025-09-30
End Date: 2029-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

962

Intervention / Treatment

The intervention will be the BRILLIANT Platform, an online platform which provides five Modules aimed at increasing coordination of care and direct rehabilitation time

Sponsor

Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Source: clinicaltrials.gov

Share:
Add to list

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

Study ID: NCT07069595
Start Date: 2025-09
End Date: 2028-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

78

Intervention / Treatment

Datopotamab deruxtecan

Circulating tumor DNA (ctDNA) testing

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories

Study ID: NCT07041281
Start Date: 2025-09-02
End Date: 2029-03-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

204

Intervention / Treatment

spironolactone 25 mg orally once daily

Placebo tablet to match spironolactone

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Single Arm Intervention Study to Assess the Acceptability, Tolerance and Ease of Use of Wilbo's Blends+ (Commercial Enteral Feed Based on Real Food) When Used as Part of a Dietitian Prescribed Enteral Feeding Plan

Study ID: NCT07036081
Start Date: 2025-09-01
End Date: 2026-03-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment
Sponsor

Nottingham University Hospitals NHS Trust

Source: clinicaltrials.gov

Share:
Add to list

Effect of Nurse-assessed Remote Ischemic Preconditioning on Improving Exercise Capacity, Endothelial Function, and Arterial Stiffness in Patients With Heart Failure With Preserved Ejection Fraction

Study ID: NCT07024810
Start Date: 2025-10-01
End Date: 2027-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

48

Intervention / Treatment

remote ischemic preconditioning

Sponsor

University of Castilla-La Mancha

Source: clinicaltrials.gov

Share:
Add to list

Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage

Study ID: NCT06968481
Start Date: 2025-10-01
End Date: 2026-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

330

Intervention / Treatment

Oxytocin

Oxytocin

Sponsor

Insud Pharma

Source: clinicaltrials.gov

Share:
Add to list

The Study Seeks to Determine Potential Correlations Between Ventilation and Hematological Alterations, Contributing to a Better Understanding of Its Physiological Effects and Optimizing Patient Management in Critical Care Settings.

Study ID: NCT07030114
Start Date: 2026-04
End Date: 2027-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

complete blood tests

mechanical ventilation (MV)

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke

Study ID: NCT07047014
Start Date: 2025-07-30
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

596

Intervention / Treatment

Tenecteplase (0.25mg/kg)

Standard medical treatment

Sponsor

Beijing Tia N-hospital

Source: clinicaltrials.gov

Share:
Add to list

Pregnancy and Infant PrEparedness pLatform IN Europe, RSV-International Adaptive Platform Trial to Evaluate Two Approved Prevention Options to Prevent Respiratory Syncytial Virus in Infants: Maternal Vaccine to Women in Pregnancy and Monoclonal Antibody to the Infants, Given Alone or in Combination.

Study ID: NCT07041190
Start Date: 2025-09
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1500

Intervention / Treatment

Abrysvo

Nirsev

Sponsor

PENTA Foundation

Source: clinicaltrials.gov

Share:
Add to list

Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations

Study ID: NCT06898138
Start Date: 2026-03-01
End Date: 2028-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

8

Intervention / Treatment

Brain Interchange System

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list